1. Programmed cell death, redox imbalance, and cancer therapeutics
   Xiaofeng Dai et al, 2021, Apoptosis CrossRef
2. In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
   Idoia Blanco-Luquin et al, 2021, Pharmaceuticals CrossRef
3. TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approaches
   Wanming Hu et al, 2024, International Immunopharmacology CrossRef
4. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
   Cristina Trejo-Solís et al, 2024, Metabolites CrossRef
5. Combination Drug Therapy of Glioblastoma: Lessons from 3D In Vitro Models and the Roadmap for Future Research
   Mahsa Vaezzadeh et al, 2023, Advanced Therapeutics CrossRef
6. Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
   Liesbeth Everix et al, 2023, Pharmaceuticals CrossRef
7. Cellular senescence in glioma
   Rafał Chojak et al, 2023, Journal of Neuro-Oncology CrossRef
8. Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma
   Michael Müller et al, 2021, Cancers CrossRef